|
Journal of Postgraduate Medicine
Medknow Publications and Staff Society of Seth GS Medical College and KEM Hospital, Mumbai, India
ISSN: 0022-3859 EISSN: 0022-3859
Vol. 49, No. 1, 2003, pp. 101-104
|
Bioline Code: jp03027
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Journal of Postgraduate Medicine, Vol. 49, No. 1, 2003, pp. 101-104
en |
Drug Review - Miltefosine: Great Expectations Against Visceral Leishmaniasis
More B, Bhatt H, Kukreja V, Ainapure SS
Abstract
Visceral leishmaniasis is a disease endemic in 47 countries and continues to be a difficult therapeutic challenge.1 There are an estimated 500 000 cases per year in Asia (primarily India), South America and South Africa. Up to half of the world's cases of visceral leishmaniasis (Kala azar) occur in India, and about 90% of patients live in the Indian state of Bihar.2
|
|
© Copyright 2003 - Journal of Postgraduate Medicine. Online full text also at http://www.jpgmonline.com Alternative site location: http://www.jpgmonline.com
|
|